JOHN H. McCONNELL

SCHOLARSHIP FUND

McConnell The Columbus Blue Jackets in partnership with the Columbus Blue Jackets Foundation, have established the John H. McConnell Scholarship Fund in honor of the team’s founder.
CURRENT PEDIATRIC CANCER RESEARCH

Research & Statistics

Research & Statistics

  • 163 new childhood cancer cases were diagnosed at Nationwide Children’s Hospital in 2006.
  • There are over 1300 children currently in cancer treatment at NCH. 
  • Nationwide Children’s Hospital follows more than 10,000 children that have undergone treatment for pediatric cancer. 
  • The cancers that attack children are unique, frequently presenting at a much more advanced stage than in adults.
Nationwide Children’s Hospital is home to a 25,000-square-foot, 28-bed inpatient unit designed on the foundation of two essential ingredients: the most advanced technology available and the indispensable input of our patients’ families. The result is a unit unlike any other pediatric cancer center in the country, where every aspect is centered around the best care of the child and the family.

NCH has the world’s largest pediatric tumor bank holding 90 percent of the tissue samples from American and Canadian cancer patients. This collection allows pathologists to make quicker, more accurate diagnoses and provides researchers access to much needed samples helping to design customized cancer treatment.

Current Research Projects

Hope Street Kids
Columbus Blue Jackets Pediatric Research Award
Case Western University

Dr. Cooke and Dr. Zhou at Case Western University set out in 2007 with their Hope Street Kids Columbus Blue Jackets’ Pediatric research grant to study the mechanisms of leukocyte recruitment to the lung during idiopathic pneumonia syndrome following an allogeneic bone marrow transplantation, a serious problem for many children diagnosed with cancer and bone marrow failure syndromes and who’s only option is an allo-BMT. Their research is not yet concluded but they hope it will help prevent and treat this serious and unpredictable complication for allo-BMT patients.